Zevra Therapeutics, Inc. (ZVRA) Stock buybacks 2020–2024
Zevra Therapeutics, Inc. (ZVRA) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$0FY2024 · since FY2020: $0 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $0 | -100.0% |
| FY2023 | $3.4M | -27.0% |
| FY2022 | $4.7M | +67.8% |
| FY2021 | $2.8M | — |
| FY2020 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ZVRA financial trends
ZVRA RevenueZVRA Net incomeZVRA Net marginZVRA Gross profitZVRA Gross marginZVRA Operating incomeZVRA Operating marginZVRA Operating cash flowZVRA Free cash flowZVRA Capital expendituresZVRA Return on equityZVRA Dividends paidZVRA Total assetsZVRA Total liabilitiesZVRA Shareholders’ equityZVRA overview →